USPTO serial 87856772
ARAN BIOMEDICAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 10, 2019
- Examiner
- PAINTER, VALERIYA SHERMAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.
Need help with ARAN BIOMEDICAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Neil B. Friedman
605 Third Avenue, Suite 2300New York, NY 10158United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Grafts, namely, skin grafts, arterial grafts; Implants comprising living tissue for treating congestive heart failure; Implantable scaffolds comprising living tissue for reinforcing tissue contour; Surgical mesh comprised primarily of living tissue for aesthetic applications; Surgical dressings, namely, pledgets; Wound closure devices and patches in the nature of adhesive bandages; all of the foregoing for use in the fields of cardiac rhythm management, gastroenterology, interventional bronchoscopy, interventional cardiology, interventional radiology, neurovascular intervention, oncology, pain management, urology, and women' s health ] | SECTION 8 - CANCELLED | — |
| 010 | Wire formed stents, laser cut stents, braided stents, covered and uncovered stents for peripheral, [ coronary, ] neurovascular, [ venous, ] endovascular, gastroenterology, [ arteriovenous shunts, ] renal stents, [ and urinary stents; Surgical synthetic stent grafts, transcatheter, synthetic bone grafts, bypass artificial vascular grafts ] ; Clot retrieval devices; Aneurysm filling devices; Peripheral vascular occluders, [ venous occluders, ] structural heart occluders; Surgical and transcatheter valve replacement devices, mitral valve replacement devices, aortic valve replacement devices, tricuspid and pulmonary valve replacement devices, surgical and transcatheter valve repair devices, mitral valve repair devices, aortic valve repair devices, tricuspid and pulmonary valve repair devices; Embolic protection devices for treating anomalies vasculature of the body; Flow-diversion devices for treating anomalies vasculature of the body; Devices and implants comprising artificial material for treating congestive heart failure; Robotic surgical instrument components and manual surgical instrument components; [ interventional balloon catheters, catheters, foreign body and polyp retrieval devices; Implantable plates, bones, pins, nails and screws, all consisting of artificial materials, Interventional vascular closure devices comprising artificial materials; Aspiration devices being electric and manual sputum aspirators, nasal aspirators; Wound drainage devices; Venous valve repair devices; Valved stents for venous, pulmonary, arterial, urinary, renal, neural and gastrointestinal applications; Heart rhythm devices in the nature of heart rate monitors; Electrophysiology devices in the nature of pacemakers and implantable cardioverter defibrillators; Neuromodulation devices in the nature of non-invasive electronic neuromodulator device for medical use by healthy and impaired persons to enhance performance; Ablation devices in the nature of cryosurgical apparatus for use in performing ablative surgery, catheters for use in cardiac ablation, radio-surgical apparatus for use in performing radiofrequency ablation; Artificial implant containment devices; Surgical instrument sheaths and sheath leads; Surgical sutures, suture passing device, suture anchors; ] Implantable scaffolds comprising artificial materials for reinforcing tissue contour; Biologic containment mesh comprised primarily of artificial materials; Spinal stabilization bands; Surgical mesh comprised primarily of artificial materials and suture for aesthetic applications; Implantable scaffolds comprising artificial materials for cartilage, bone and ligament repair; Hernia repair surgical meshes comprised primarily of artificial materials; Urinary slings for bladder control; Surgical meshes comprised primarily of artificial materials for pelvic prolapse; [ Penile implants consisting of artificial materials; Cerclage cables and wound closure devices in the nature of sutures; ] Medical textiles composed of artificial materials, namely, polymeric and metallic textiles and resorbable synthetic biomaterial structures for use in orthopedic, cardiovascular, general surgical and regenerative medicine applications; Medical textiles composed of artificial materials for use in surgical applications, namely, woven, non-woven, knitted and braided polymeric, resorbable and metallic textile structures; [ Implantable medical textiles composed of artificial materials for use in orthopedic, cardiovascular, and general surgery; Implantable medical textiles composed of synthetic biomaterials for regenerative medicine and for use in orthopedic, cardiovascular, neurovascular, and general surgery; Implantable synthetic bioresorbable materials for medical use, namely, bioresorbable resinous oligomers and polymers for therapeutic and reconstructive use and for use in regenerative medicine, tissue engineering and wound care; ] All of the foregoing being medical, dental and surgical apparatus, implants, devices and instruments for use in the fields of cardiac rhythm management, gastroenterology, interventional bronchoscopy, interventional cardiology, interventional radiology, neurovascular intervention, oncology, pain management, urology, and women' s health | ACTIVE | — |
| 040 | Manufacturing services, namely, custom manufacturing of parts and components for use in medical devices to the order and/or specification of others; Manufacturing and fabrication services of medical components and materials for others, in the nature of medical devices; Custom manufacturing of medical devices, medical instruments, implantable medical devices and their structural components; Processing of medical components, namely, manufacturing of wire formed stents, [ laser cut stents, ] braided stents, covered and uncovered stents for peripheral, coronary, neurovascular, venous, endovascular, gastroenterology, arteriovenous shunts, renal stents, and urinary stents, [ surgical grafts ] transcatheter grafts [ bypass grafts] , clot retrieval devices, aneurysm filling devices, peripheral occluders, venous occluders, structural heart occluders, surgical and transcatheter valve replacement devices, mitral valve replacement devices, aortic valve replacement devices, tricuspid and pulmonary valve replacement devices, surgical and transcatheter valve repair devices, mitral valve repair devices, aortic valve repair devices, tricuspid and pulmonary valve repair devices, embolic protection devices, flowdiversion devices, heart failure devices and implants, [ robotic surgical instrument components and manual surgical instrument components, ] interventional delivery and access systems, interventional balloon, catheters, retrieval devices, [ implantable plates, bones, pins, nails and screws, ] interventional closure devices., aspiration devices, drainage devices, [ filtration devices, venous valve repair devices, valved stents for venous, pulmonary, arterial, urinary, renal, neural and gastrointestinal applications, heart rhythm devices, electrophysiology devices, neuromodulation devices, ablation devices, ] implant containment devices, [ sheaths and sheath leads, surgical pledgets, ] sutures, suture passing device, [ suture anchors, ] tissue reinforcement scaffolds, [ biologic containment mesh, ] spinal stabilization bands, mesh and suture for aesthetic applications, [ scaffolds for cartilage, bone and ligament repair, ] hernia repair meshes, urinary slings for bladder control, meshes for pelvic prolapse [ , penile implants, cerclage cables, and wound closure devices and patches ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Aran Biomedical Teoranta
- Other trademarks owned by Aran Biomedical Teoranta
- Other trademarks owned by Aran Biomedical Teoranta
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 040
- Similar marks named ARAN BIOMEDICAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 14, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 14, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 14, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 14, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 18, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Aug 18, 2025 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Aug 7, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 4, 2025 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Dec 10, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 22, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 22, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 22, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 22, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 22, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 22, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 10, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 24, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 24, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 4, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 20, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 17, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 17, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 17, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 17, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 12, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 12, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 12, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 8, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 8, 2019 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 8, 2019 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 8, 2019 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jan 23, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 23, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 23, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 23, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 17, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 6, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 3, 2018 | NWAP | NEW APPLICATION ENTERED | — |